Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2018 AND VI 36 AND IP 4
Results: 12
1
2
The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
Cost Effectiveness of Alectinib vs. Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
8
Is ICER NICEr?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
9
Cost Effectiveness of Treatments for Chronic Constipation: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).
- Published in:
- 2018
- By:
- Publication type:
- journal article
11
Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
12
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article